secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0000950170-23-029063
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix enters enhanced severance agreements with CEO, CFO, and three other officers
--------------------------------------------------------------------------------

- CEO Valentine gets 1.5x salary+target bonus severance (2.99x in CiC period through Jan 2025); other executives get 1.0x (1.5x in CiC).
- SeaSpine merger (Jan 5, 2023) triggers CiC period running through Jan 4, 2025 for all agreements.
- COBRA reimbursement: up to 18 months for CEO; up to 12 months for other executives; equity awards get partial/full acceleration.
- Agreements supersede prior employment agreements (Valentine), SeaSpine retention plan (Bostjancic, Keran), and prior severance deals (Elting, Kenny).
- No minimum compensation guaranteed; benefits conditioned on signing release and compliance with non-compete/solicitation covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000095017023029063/0000950170-23-029063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000095017023029063/ofix-20230619.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-029063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer